000			03032nam a22003615i 4500
988			_aSpringer_Medicine_2015
999			_c81990 _d81990 _x1
001			81990
003			ES-MaUEC
005			20230207040350.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			140913s2015 xxu| s |||| 0|eng d
020			_a9781493915019
024	7		_a10.1007/978-1-4939-1501-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280.B5 _b2015 EB
245	0	0	_aUpper Tract Urothelial Carcinoma _cedited by Shahrokh F. Shariat, Evanguelos Xylinas.
260			_c
264		1	_aNew York _bSpringer
300			_a1 recurso en línea (XI, 198 p.) _b36 ilustraciones, 33 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aEpidemiology and risk factors for upper urinary urothelial cancers -- Diagnosis and Evaluation of Upper Tract Urothelial Carcinoma (UTUC) -- Upper Urinary Tract Urothelial Carcinoma Pathology -- Prognostics factors, molecular markers and predictive tools in upper tract urothelial carcinoma -- Conservative management of low-risk UTUC -- Surgical Management of High-risk Upper Tract Urothelial Carcinoma -- The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract -- Chemotherapy.
520			_aUpper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. Its aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage andpatient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy are covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Â{u0570}per Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists, and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.
650		7	_9667082 _aVejiga _2embne _xCáncer
700	1		_aShariat, Shahrokh F _eeditor literario _994598 _0Local
700	1		_aXylinas, Evanguelos _eeditor literario _994599 _0Local
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-1501-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b11/2020 _dz _eIG _feng _gxxu _h0